Commerce Bank bought a new position in Synopsys, Inc. (NASDAQ:SNPS - Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor bought 9,208 shares of the semiconductor company's stock, valued at approximately $4,107,000.
A number of other institutional investors have also added to or reduced their stakes in the stock. Sankala Group LLC purchased a new stake in Synopsys during the 4th quarter valued at $25,000. Elevation Wealth Partners LLC raised its stake in shares of Synopsys by 96.4% in the second quarter. Elevation Wealth Partners LLC now owns 55 shares of the semiconductor company's stock valued at $25,000 after acquiring an additional 27 shares during the period. IMG Wealth Management Inc. bought a new stake in shares of Synopsys in the 2nd quarter worth about $28,000. Caitong International Asset Management Co. Ltd bought a new stake in shares of Synopsys in the 4th quarter worth about $28,000. Finally, Atlas Capital Advisors Inc. purchased a new position in shares of Synopsys during the 4th quarter worth about $32,000. 85.47% of the stock is owned by hedge funds and other institutional investors.
Synopsys Trading Down 0.8%
Shares of SNPS opened at $394.51 on Tuesday. The firm has a market capitalization of $75.54 billion, a price-to-earnings ratio of 91.32, a PEG ratio of 2.34 and a beta of 1.23. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.43 and a quick ratio of 1.32. Synopsys, Inc. has a 1-year low of $366.00 and a 1-year high of $615.79. The company has a 50-day moving average of $418.53 and a 200 day moving average of $439.92.
Synopsys (NASDAQ:SNPS - Get Free Report) last issued its earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 EPS for the quarter, topping analysts' consensus estimates of $3.15 by $0.20. Synopsys had a net margin of 8.91% and a return on equity of 5.83%. The business had revenue of $2.28 billion for the quarter, compared to analyst estimates of $2.25 billion. During the same period last year, the company posted $3.67 earnings per share. The company's quarterly revenue was up 41.9% compared to the same quarter last year. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. On average, research analysts expect that Synopsys, Inc. will post 10.64 EPS for the current year.
Insiders Place Their Bets
In other Synopsys news, CFO Shelagh Glaser sold 3,394 shares of Synopsys stock in a transaction on Friday, June 12th. The stock was sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the completion of the sale, the chief financial officer directly owned 14,358 shares of the company's stock, valued at $6,461,387.16. The trade was a 19.12% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of the company's stock in a transaction on Monday, June 15th. The stock was sold at an average price of $458.96, for a total value of $6,702,192.88. Following the completion of the sale, the chief executive officer owned 75,020 shares of the company's stock, valued at $34,431,179.20. This represents a 16.29% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders own 0.56% of the company's stock.
Analysts Set New Price Targets
Several equities analysts recently commented on SNPS shares. Bank of America upped their price target on shares of Synopsys from $515.00 to $600.00 and gave the company a "buy" rating in a report on Thursday, May 28th. Morgan Stanley dropped their target price on Synopsys from $525.00 to $500.00 and set an "equal weight" rating for the company in a research report on Wednesday, August 19th. Weiss Ratings reaffirmed a "hold (c-)" rating on shares of Synopsys in a research note on Monday, June 8th. Piper Sandler upgraded Synopsys from a "neutral" rating to an "overweight" rating and increased their price target for the stock from $450.00 to $550.00 in a report on Tuesday, June 23rd. Finally, BNP Paribas Exane raised their price target on Synopsys from $425.00 to $450.00 and gave the stock an "underperform" rating in a research note on Thursday, May 28th. One research analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, Synopsys currently has a consensus rating of "Moderate Buy" and an average price target of $563.59.
View Our Latest Report on Synopsys
About Synopsys
(
Free Report)
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Featured Stories
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.